| Akt | protein kinase B |
| AP-1 | activator protein-1 |
| CaMKI, II or III | Ca2+/calmodulin-dependent protein kinase |
| CBP | CREB-binding protein |
| CRE | Ca2+/cAMP-response element |
| DEGs | differentially expressed genes |
| EGM-2 | endothelial cell growth medium-2 |
| ERG | Early response genes |
| FBS | fetal bovine serum |
| FOXO | forkhead box protein O |
| HeLa | human adenocarcinoma cell line |
| HUVEC | human umbilical vein endothelial cells |
| INFκB | inhibitor of nuclear factor kappa-B |
| IRG | Intermediate response genes |
| LRG | late response genes |
| MAPK | mitogen-activated protein kinases |
| mTOR | mammalian target of rapamycin |
| NFAT | nuclear factor of activated T-cells |
| PCA | principal component analysis |
| PI (3)K | phosphatidyl inositol 3-kinase |
| PKA | cAMP-dependent protein kinase A |
| PKC | cAMP-dependent protein kinase C |
| PtdIns3 ps or PI3P | phosphatidylinositol 3-phosphate |
| RVSM | rat vascular smooth muscle cells |
| SRE | serum response element |
| UTR | 5′-untranslated region |